116 related articles for article (PubMed ID: 21192969)
1. 5-HT6 pharmacology inconsistencies.
Borsini F; Bordi F; Riccioni T
Pharmacol Biochem Behav; 2011 Apr; 98(2):169-72. PubMed ID: 21192969
[TBL] [Abstract][Full Text] [Related]
2. [Serotonin and impulsivity (experiments on animals)].
Grigor'ian GA
Zh Vyssh Nerv Deiat Im I P Pavlova; 2011; 61(3):261-73. PubMed ID: 21861382
[TBL] [Abstract][Full Text] [Related]
3. Serotonin receptors of type 6 (5-HT6): what can we expect from them?
Marazziti D; Baroni S; Catena Dell'Osso M; Bordi F; Borsini F
Curr Med Chem; 2011; 18(18):2783-90. PubMed ID: 21649582
[TBL] [Abstract][Full Text] [Related]
4. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
[TBL] [Abstract][Full Text] [Related]
5. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
Yun HM; Rhim H
Toxicol In Vitro; 2011 Dec; 25(8):2035-40. PubMed ID: 21864673
[TBL] [Abstract][Full Text] [Related]
6. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
Wesołowska A
Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
[TBL] [Abstract][Full Text] [Related]
7. Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.
Marazziti D; Baroni S; Borsini F; Picchetti M; Vatteroni E; Falaschi V; Catena-Dell'Osso M
Curr Med Chem; 2013; 20(3):371-7. PubMed ID: 23157629
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of 5-HT6 receptor antagonists.
Reavill C; Rogers DC
Curr Opin Investig Drugs; 2001 Jan; 2(1):104-9. PubMed ID: 11527001
[No Abstract] [Full Text] [Related]
9. [The agonists of I-A serotoninergic receptors restore in rats behavior impaired by L-dihydroxyphenylalanine].
Bondarenko NA; Bondarenko NA; Baran L; Klodzinska A
Biull Eksp Biol Med; 1990 Dec; 110(12):627-8. PubMed ID: 2083366
[TBL] [Abstract][Full Text] [Related]
10. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
Wesołowska A; Jastrzębska-Więsek M
Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784
[No Abstract] [Full Text] [Related]
11. Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat.
Gasbarri A; Cifariello A; Pompili A; Meneses A
Behav Brain Res; 2008 Dec; 195(1):164-70. PubMed ID: 18308404
[TBL] [Abstract][Full Text] [Related]
12. Effects of serotonin 1A agonist on acute spinal cord injury.
Saruhashi Y; Matsusue Y; Hukuda S
Spinal Cord; 2002 Oct; 40(10):519-23. PubMed ID: 12235534
[TBL] [Abstract][Full Text] [Related]
13. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
14. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
15. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Glennon RA
J Med Chem; 2003 Jul; 46(14):2795-812. PubMed ID: 12825922
[No Abstract] [Full Text] [Related]
16. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
Filip M; Papla I; Nowak E; Jungersmith K; Przegaliński E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):226-34. PubMed ID: 12172705
[TBL] [Abstract][Full Text] [Related]
17. Serotonin receptor and reuptake sites: pharmacologic significance.
Gonzalez-Heydrich J; Peroutka SJ
J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
[TBL] [Abstract][Full Text] [Related]
18. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
19. 5-HT: the promiscuous and happy hormone!
Barnes NM
Curr Opin Pharmacol; 2011 Feb; 11(1):1-2. PubMed ID: 21420360
[No Abstract] [Full Text] [Related]
20. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
